4.7 Article

The predictive value of cardiorespiratory fitness for cardiovascular events in men with various risk profiles: a prospective population-based cohort study

期刊

EUROPEAN HEART JOURNAL
卷 25, 期 16, 页码 1428-1437

出版社

OXFORD UNIV PRESS
DOI: 10.1016/j.ehj.2004.06.013

关键词

coronary heart disease; exercise test; mortality; myocardial infarction; risk factor

资金

  1. NHLBI NIH HHS [HL44199] Funding Source: Medline

向作者/读者索取更多资源

Aims Few data exist to show if the prognostic value of peak exercise oxygen consumption (VO2peak) for fatal and non-fatal coronary events is different among men with low and high pre-test probability for cardiovascular disease (CVD). Our objective was to determine whether VO2peak could predict fatal and non-fatal cardiac events in 2361 men aged 42-60 years with and without conventional risk predictors of CVD or with documented CVD during a 13-year follow-up. Methods and Results Maximal. oxygen consumption (ml/kg/min) was measured directly by using respiratory gas exchange in a cycle ergometer exercise test. Of 204 CVD deaths, 153 were due to coronary disease and 51 were due to other CVDs. A total of 323 non-fatal coronary events occurred during the follow-up. One metabolic equivalent (MET) increment in VO2peak was related to a decreased risk of coronary death in both healthy (RR=0.82, 95% Cl 0.66-0.99) and unhealthy (RR=0.72, 95% Cl 0.63-0.82) men. VO2peak was predictive of non-fatal and fatal cardiac events among men with or without known risk factors. In subjects with or without common risk factors, one MET increment amounted to an average decrease of 17-29% in non-fatal and 28-51% in fatal cardiac events, after adjustment for age. VO2peak and smoking represented two strongest independent and consistent risk predictors. Conclusions VO2peak can be used as a very powerful predictor of future fatal cardiac events beyond that predicted by many conventional risk factors. On the prognostic consideration, unfit men with unfavourabte risk profiles or underlying chronic disease are the risk groups that will benefit most from preventive measures. (C) 2004 Published by Elsevier Ltd on behalf of The European Society of Cardiology.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据